Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Padjadjaran University

Indonesia · Asia-Pacific

#827World rank of 1,038
32.1ICI scoreout of 100
#1National rank, of 5 in Indonesia
#266Regional rank, of 343 in Asia-Pacific
203.5Verified industry works, 2021 to 2025
75Company groups worked with (29 on two or more works)

Padjadjaran University is ranked #827 of 1,038. Its strongest pillar is durability (88): 10 of its company groups are sustained partners (five or more joint works in three or more of the five years). It is held back most by co-creation (7): 203.5 verified industry works against about 604 expected for its mix of fields; and by scale (26): a network of 29 company groups on two or more joint works.

Research Collaboration Index 2026: #1112 of 1,195 · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
7

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 203.5 verified works against about 604 expected for its fields (0.34 times the expected rate).

Durability20% of the score
88

How much of its industry work sits in sustained partnerships with the same company group. 10 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
26

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 29 company groups on two or more joint works; 10 sustained partnerships.

Breadth20% of the score
24

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (32.1) is the weighted average of the four percentiles. Rank 827 of 1,038 overall; 1 of 5 in Indonesia; 266 of 343 in Asia-Pacific. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

0.8%of its 27,193 research works in 2021 to 2025 were co-authored with a verified company
0.34Industry co-authorship rate: 0.34 times what its mix of research fields would predict (203.5 verified works; about 604 expected)
10sustained partnerships: the same company group on five or more joint works in three or more of the five years

In Indonesia

1 of 5 ranked universities in Indonesia

  1. #1 Padjadjaran University world #827, score 32.1
  2. #2 University of Indonesia world #834, score 31.7
  3. #3 Universitas Gadjah Mada world #954, score 24.8
  4. #4 Bandung Institute of Technology world #959, score 24.5
  5. #5 Airlangga University world #989, score 20.9

All ranked universities →   Asia-Pacific: 266 of 343 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Not yet ranked in any sector: a sector ranking needs at least 20 verified works in the sector. Its largest sector is Biotechnology and Advanced Therapies, with 18.5.

Biotechnology and Advanced Therapies
18.5under 20 works
Agriculture and Food Technology
16.5under 20 works
Pharmaceuticals and Therapeutics
12.5under 20 works
Climate, Environment and Sustainability
7under 20 works
Medical Technology and Digital Health
6under 20 works
Clean Energy Transition
2under 20 works
Advanced Manufacturing and Industry 4.0
1under 20 works
Advanced Materials and Nanotechnology
1under 20 works
Artificial Intelligence
1under 20 works
Chemicals, Process and Resources
1under 20 works
Next-Generation Communications
1under 20 works
Not in any of the 21 sectors
136counted in the overall index

67.5 of its 203.5 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Padjadjaran University co-authored verified work with 75 company groups, consortium papers aside: 29 of them on two or more works, and 10 as sustained partners.

The largest 12 of its 75 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
PT Bio FarmaIndonesiaMedicine385 of 5
PertaminaSTATE-OWNEDIndonesiaEngineering37.55 of 5
PT Prodia StemCell IndonesiaIndonesiaMedicine24.55 of 5
KarsaFinlandMedicine10.55 of 5
Sensient TechnologiesUnited StatesAgricultural and Biological Sciences9.54 of 5
GlaxoSmithKlineUnited KingdomMedicine85 of 5
ValnevaAustriaMedicine72 of 5
AstraZenecaUnited KingdomMedicine64 of 5
Johnson & JohnsonUnited StatesMedicine64 of 5
SeqirusUnited StatesMedicine63 of 5
PfizerUnited StatesMedicine53 of 5
Merck & Co. (MSD)United StatesMedicine42 of 5

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Over time

Verified industry works by year

292021
34.52022
47.52023
472024
45.52025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

7 industry-partnered clinical trials

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

Examples:

  • NCT06925386 The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment with PT. Prodia Stem Cell Indonesia, 2025
  • NCT06690515 Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants with PT Bio Farma, 2025
  • NCT06537336 Optimizing Pulmonary Health and Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial Combining Incentive Spirometry and Aerobic Exercise with Hermina Hospitals, 2023
  • NCT05727215 Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age with PT Bio Farma, 2023
  • NCT05525208 Booster Study of COVID-19 Protein Subunit Recombinant Vaccine with PT Bio Farma, 2022
  • NCT05808231 Effectiveness and Safety of Quinine Sulfate as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia ( DEAL-COVID19 ) with Prodia Diacro Laboratories P.T., 2021

Evidence checked

274 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 245 of 519 candidate links were set aside.

Why links were set aside
  • 179 company name not written in the author's affiliation
  • 20 a place or common word that failed its stricter rule
  • 15 ordinary-word name without a company suffix
  • 10 part of a university or public institute's own unit
  • 6 a list of companies, not an address
  • 3 excluded after hand audit: Matched from social media handles in affiliation text
  • 12 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

GRP Partnership Intelligence Platform

Where Padjadjaran University's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Padjadjaran University ranks #1112 of 1,195. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.